Your browser doesn't support javascript.
loading
[Evaluation of the performance of InnowaveDX MTB/RIF for the detection of Mycobacterium tuberculosis complex and rifampicin resistance].
Wang, Y P; Tan, Y H; Li, X; Wang, J; Chen, C G; Xu, J; Xiang, J.
Afiliação
  • Wang YP; Department of Emergency, Hubei Provincial Hospital of TCM, Wuhan 430060, China.
  • Tan YH; Department of Clinical Laboratory, Hunan Institute For Tuberculosis Control, Changsha 410205, China.
  • Li X; Department of Clinical Laboratory, Henan Infectious Disease Hospital, Zhengzhou 450015, China.
  • Wang J; Department of Clinical Laboratory, Hunan Institute For Tuberculosis Control, Changsha 410205, China.
  • Chen CG; Department of Clinical Laboratory, Henan Infectious Disease Hospital, Zhengzhou 450015, China.
  • Xu J; Department of Clinical Laboratory, Wuhan Jinyintan Hospital, Wuhan 430023, China.
  • Xiang J; Department of Clinical Laboratory, Wuhan Jinyintan Hospital, Wuhan 430023, China.
Zhonghua Jie He He Hu Xi Za Zhi ; 46(7): 658-663, 2023 Jul 12.
Article em Zh | MEDLINE | ID: mdl-37402655
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Pulmonar / Tuberculose Resistente a Múltiplos Medicamentos / Antibióticos Antituberculose / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Pulmonar / Tuberculose Resistente a Múltiplos Medicamentos / Antibióticos Antituberculose / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article